Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Liquid biopsy offers minimally invasive cancer detection.
• Tumor-educated platelets (TEPs) are a promising source for cancer biomarkers.
• Early detection of Non-small Cell Lung Carcinoma (NSCLC) improves patient outcomes.

Purpose of the Study:

• To develop and validate a TEP-based liquid biopsy for NSCLC detection.
• To identify a robust RNA biomarker panel for NSCLC diagnosis.
• To assess the clinical utility of TEPs in blood tests.

Main Methods:

• Analysis of TEPs from 466 NSCLC patients and 410 controls using the thromboSeq protocol.
• Development of a particle-swarm optimization machine learning algorithm.
• Selection of an 881 RNA biomarker panel.
• Validation in an independent cohort of 558 samples.

Main Results:

• An 881 RNA biomarker panel was identified with an AUC of 0.88.
• Two testing approaches were validated: high sensitivity (95% NSCLC detection) and high specificity (94% control detection).
• TEP-derived spliced RNAs demonstrated diagnostic potential.

Conclusions:

• TEP-derived spliced RNAs can serve as biomarkers for minimally invasive NSCLC blood tests.
• This approach complements existing imaging tests for lung cancer detection.
• TEP analysis aids in the detection and management of lung cancer patients.